Feed RNMBY
RN

Rheinmetall AG RNMBY · OTC

$237.26 -3.45% (-$8.48)

Summary

59 / 100 · Bulios Score

What speaks for it

  • Earnings per share grew by 26% a year over the last 3 years.
  • Analysts expect revenue to grow by 48% this fiscal year.
  • It earns 12 EUR a year on every 100 EUR of invested capital.

What to watch

  • The share price is above the Bulios Fair Price.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Looks expensive
Bulios Fair Price
Current price $237.26
5-year average P/E 32.2 101% higher
P/E today 64.8
Aerospace & Defense industry median
P/E today 64.8

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Today you pay 64.8 EUR for 1 EUR of yearly profit. Over the last five years it was 32.2 EUR on average.

Valuation in detail

Is it growing?

Yes, fast

Revenue (EUR)

Diluted EPS (EUR)

  • Analyst estimate

Revenue grew by 10% a year over 5 years. Over the last 3 years it grew by 14% a year. For the next fiscal year analysts expect revenue to grow by 48%. Earnings per share grew by 26% a year over the last 3 years.

Growth in detail

Does it make money?

Reasonably

Where 100 EUR of revenue goes

Net profit, industry median (Aerospace & Defense) 7.5 EUR

Out of every 100 EUR of revenue, 6.8 EUR is left as net profit.

Profitability in detail

Is it financially healthy?

Debt is a burden

Repaying all its debt would take 11.7 years of free cash flow. Its debt is larger than its cash. The debt score is high even so.

Financial health in detail

Does it pay a dividend?

Small, stretched
Yield
1.12%
Paid out of profit
73%
Raised in a row
4 years

You receive $2.67 per share a year. The payout takes a large part of its profit or free cash flow.

Dividends in detail

What do analysts expect?

Mildly positive

No analyst has published a price target.

100% of the analysts recommend buying.

Analysts in detail

What does it earn on?

By product

The company reports no revenue by product.

By region

The company reports no revenue by region.

Segments in detail

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.